Trial Outcomes & Findings for Reletex for Nausea in GERD Patients (NCT NCT01582100)

NCT ID: NCT01582100

Last Updated: 2014-11-13

Results Overview

number of events of nausea with or without vomiting in patients with GERD in 4 weeks

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

2 participants

Primary outcome timeframe

4 weeks

Results posted on

2014-11-13

Participant Flow

two subjects were recruited in clinic. One withdrew after experiencing minor wrist discomfort, the other withdrew after determining the visit schedule undesirable.

Participant milestones

Participant milestones
Measure
GERD Subjects With Nausea
Subjects who present with GERD along with nausea (with or without vomiting)
Overall Study
STARTED
2
Overall Study
COMPLETED
0
Overall Study
NOT COMPLETED
2

Reasons for withdrawal

Reasons for withdrawal
Measure
GERD Subjects With Nausea
Subjects who present with GERD along with nausea (with or without vomiting)
Overall Study
Adverse Event
1
Overall Study
Withdrawal by Subject
1

Baseline Characteristics

Reletex for Nausea in GERD Patients

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
GERD Subjects With Nausea
n=2 Participants
Subjects who present with GERD along with nausea (with or without vomiting)
Age, Categorical
<=18 years
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
2 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
Sex: Female, Male
Female
2 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 4 weeks

number of events of nausea with or without vomiting in patients with GERD in 4 weeks

Outcome measures

Outcome data not reported

Adverse Events

Wrist Discomfort

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Christine Ebert Nelson

Northwestern University

Phone: 3126954513

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place